| Year |
Citation |
Score |
| 2024 |
Sahoo S, Ramu S, Nair MG, Pillai M, San Juan BP, Milioli HZ, Mandal S, Naidu CM, Mavatkar AD, Subramaniam H, Neogi AG, Chaffer CL, Prabhu JS, Somarelli JA, Jolly MK. Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer. Iscience. 27: 110116. PMID 38974967 DOI: 10.1016/j.isci.2024.110116 |
0.407 |
|
| 2024 |
Desai P, Takahashi N, Kumar R, Nichols S, Malin J, Hunt A, Schultz C, Cao Y, Tillo D, Nousome D, Chauhan L, Sciuto L, Jordan K, Rajapakse V, Tandon M, ... ... Jolly MK, et al. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities. Cell Reports. Medicine. 5: 101610. PMID 38897168 DOI: 10.1016/j.xcrm.2024.101610 |
0.355 |
|
| 2024 |
Nair MG, Mavatkar AD, Naidu CM, V P S, C E A, Rajarajan S, Sahoo S, Mohan G, Jaikumar VS, Ramesh RS, B S S, Jolly MK, Maliekal TT, Prabhu JS. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer. Cells. 13. PMID 38786043 DOI: 10.3390/cells13100821 |
0.321 |
|
| 2024 |
Sai Prasanna CV, Jolly MK, Bhat R. Spatial heterogeneity in tumor adhesion qualifies collective cell invasion. Biophysical Journal. PMID 38725244 DOI: 10.1016/j.bpj.2024.05.005 |
0.381 |
|
| 2024 |
Bv H, Jolly MK. Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma. Iscience. 27: 109184. PMID 38433919 DOI: 10.1016/j.isci.2024.109184 |
0.34 |
|
| 2024 |
Sharma S, Rani H, Mahesh Y, Jolly MK, Dixit J, Mahadevan V. Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer. Translational Oncology. 43: 101848. PMID 38412660 DOI: 10.1016/j.tranon.2023.101848 |
0.333 |
|
| 2024 |
Prasad H, Mandal S, Mathew JKK, Cherukunnath A, Duddu AS, Banerjee M, Ramani H, Bhat R, Jolly MK, Visweswariah SS. An endosomal acid-regulatory feedback system rewires cytosolic cAMP metabolism and drives tumour progression. Molecular Cancer Research : McR. PMID 38319300 DOI: 10.1158/1541-7786.MCR-23-0606 |
0.339 |
|
| 2024 |
Sehgal M, Nayak SP, Sahoo S, Somarelli JA, Jolly MK. Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma. Cancer Biology & Therapy. 25: 2301802. PMID 38230570 DOI: 10.1080/15384047.2024.2301802 |
0.387 |
|
| 2024 |
Solaimuthu B, Khatib A, Tanna M, Karmi A, Hayashi A, Abu Rmaileh A, Lichtenstein M, Takoe S, Jolly MK, Shaul YD. The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness. Proceedings of the National Academy of Sciences of the United States of America. 121: e2316733121. PMID 38215181 DOI: 10.1073/pnas.2316733121 |
0.474 |
|
| 2023 |
Biswas A, Sahoo S, Riedlinger GM, Ghodoussipour S, Jolly MK, De S. Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma. Communications Biology. 6: 1292. PMID 38129585 DOI: 10.1038/s42003-023-05668-3 |
0.321 |
|
| 2023 |
Catalanotto M, Vaz JM, Abshire C, Youngblood R, Chu M, Levine H, Jolly MK, Dragoi AM. Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP). Translational Oncology. 39: 101837. PMID 37984255 DOI: 10.1016/j.tranon.2023.101837 |
0.593 |
|
| 2023 |
Shyam S, Ramu S, Sehgal M, Jolly MK. A systems-level analysis of the mutually antagonistic roles of RKIP and BACH1 in dynamics of cancer cell plasticity. Journal of the Royal Society, Interface. 20: 20230389. PMID 37963558 DOI: 10.1098/rsif.2023.0389 |
0.4 |
|
| 2023 |
Sahoo S, Ramu S, Nair MG, Pillai M, San Juan BP, Milioli HZ, Mandal S, Naidu CM, Mavatkar AD, Subramaniam H, Neogi AG, Chaffer CL, Prabhu JS, Somarelli JA, Jolly MK. Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer. Biorxiv : the Preprint Server For Biology. PMID 37873432 DOI: 10.1101/2023.09.30.558960 |
0.398 |
|
| 2023 |
Thankamony AP, Ramkomuth S, Ramesh ST, Murali R, Chakraborty P, Karthikeyan N, Varghese BA, Jaikumar VS, Jolly MK, Swarbrick A, Nair R. Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer. Frontiers in Oncology. 13: 1230647. PMID 37841442 DOI: 10.3389/fonc.2023.1230647 |
0.36 |
|
| 2023 |
Jain P, Pillai M, Duddu AS, Somarelli JA, Goyal Y, Jolly MK. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity. Seminars in Cancer Biology. 96: 48-63. PMID 37788736 DOI: 10.1016/j.semcancer.2023.09.007 |
0.418 |
|
| 2023 |
Subhadarshini S, Sahoo S, Debnath S, Somarelli JA, Jolly MK. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity. Journal For Immunotherapy of Cancer. 11. PMID 37678920 DOI: 10.1136/jitc-2023-006766 |
0.334 |
|
| 2023 |
Thurakkal B, Hari K, Marwaha R, Karki S, Jolly MK, Das T. Collective heterogeneity of mitochondrial potential in contact inhibition of proliferation. Biophysical Journal. PMID 37598292 DOI: 10.1016/j.bpj.2023.08.014 |
0.305 |
|
| 2023 |
Najafi A, Jolly MK, George JT. Population dynamics of EMT elucidates the timing and distribution of phenotypic intra-tumoral heterogeneity. Iscience. 26: 106964. PMID 37426354 DOI: 10.1016/j.isci.2023.106964 |
0.385 |
|
| 2023 |
Subhadarshini S, Sahoo S, Debnath S, Somarelli JA, Jolly MK. Dynamical modelling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity. Biorxiv : the Preprint Server For Biology. PMID 37398358 DOI: 10.1101/2023.01.09.523355 |
0.319 |
|
| 2023 |
Adler FR, Anderson ARA, Bhushan A, Bogdan P, Bravo-Cordero JJ, Brock A, Chen Y, Cukierman E, DelGiorno KE, Denis GV, Ferrall-Fairbanks MC, Gartner ZJ, Germain RN, Gordon DM, Hunter G, ... Jolly MK, et al. Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation. Cell Systems. 14: 252-257. PMID 37080161 DOI: 10.1016/j.cels.2023.03.002 |
0.498 |
|
| 2023 |
Subhadarshini S, Markus J, Sahoo S, Jolly MK. Dynamics of Epithelial-Mesenchymal Plasticity: What Have Single-Cell Investigations Elucidated So Far? Acs Omega. 8: 11665-11673. PMID 37033874 DOI: 10.1021/acsomega.2c07989 |
0.448 |
|
| 2023 |
Subbalakshmi AR, Sahoo S, Manjunatha P, Goyal S, Kasiviswanathan VA, Mahesh Y, Ramu S, McMullen I, Somarelli JA, Jolly MK. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition. Journal of Biological Engineering. 17: 17. PMID 36864480 DOI: 10.1186/s13036-023-00333-z |
0.35 |
|
| 2023 |
Jindal R, Nanda A, Pillai M, Ware KE, Singh D, Sehgal M, Armstrong AJ, Somarelli JA, Jolly MK. Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer. Computational and Structural Biotechnology Journal. 21: 1498-1509. PMID 36851919 DOI: 10.1016/j.csbj.2023.01.031 |
0.306 |
|
| 2023 |
Jain P, Corbo S, Mohammad K, Sahoo S, Ranganathan S, George JT, Levine H, Taube J, Toneff M, Jolly MK. Epigenetic memory acquired during long-term EMT induction governs the recovery to the epithelial state. Journal of the Royal Society, Interface. 20: 20220627. PMID 36628532 DOI: 10.1098/rsif.2022.0627 |
0.472 |
|
| 2022 |
Rashid M, Hari K, Thampi J, Santhosh NK, Jolly MK. Network topology metrics explaining enrichment of hybrid epithelial/mesenchymal phenotypes in metastasis. Plos Computational Biology. 18: e1010687. PMID 36346808 DOI: 10.1371/journal.pcbi.1010687 |
0.379 |
|
| 2022 |
Saxena K, Subbalakshmi AR, Kulkarni P, Jolly MK. . Journal of Biosciences. 47. PMID 36210746 |
0.347 |
|
| 2022 |
Biswas K, Jolly MK, Ghosh A. Mean residence times of TF-TF and TF-miRNA toggle switches. Journal of Biosciences. 47. PMID 36210728 |
0.379 |
|
| 2022 |
Aggarwal V, Sahoo S, Donnenberg VS, Chakraborty P, Jolly MK, Sant S. P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration. Advances in Cancer Biology - Metastasis. 5. PMID 36187341 DOI: 10.1016/j.adcanc.2022.100057 |
0.395 |
|
| 2022 |
Jain P, Duddu AS, Jolly MK. Stochastic population dynamics of cancer stemness and adaptive response to therapies. Essays in Biochemistry. 66: 387-398. PMID 36073715 DOI: 10.1042/EBC20220038 |
0.322 |
|
| 2022 |
Pillai M, Rajaram G, Thakur P, Agarwal N, Muralidharan S, Ray A, Barbhaya D, Somarelli JA, Jolly MK. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis. Frontiers in Oncology. 12: 913803. PMID 36003764 DOI: 10.3389/fonc.2022.913803 |
0.407 |
|
| 2022 |
More MH, Varankar SS, Naik RR, Dhake RD, Ray P, Bankar RM, Mali AM, Subbalakshmi AR, Chakraborty P, Jolly MK, Bapat SA. A Multistep Tumor Growth Model of High Grade Serous Ovarian Carcinoma Identifies Hypoxia Associated Signatures. Cells, Tissues, Organs. PMID 35970135 DOI: 10.1159/000526432 |
0.301 |
|
| 2022 |
Brown MS, Abdollahi B, Wilkins OM, Lu H, Chakraborty P, Ognjenovic NB, Muller KE, Jolly MK, Christensen BC, Hassanpour S, Pattabiraman DR. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer. Science Advances. 8: eabj8002. PMID 35921406 DOI: 10.1126/sciadv.abj8002 |
0.426 |
|
| 2022 |
Jia W, Duddu AS, Jolly MK, Levine H. Lack of Correlation between Landscape Geometry and Transition Rates. The Journal of Physical Chemistry. B. 126: 5613-5618. PMID 35876849 DOI: 10.1021/acs.jpcb.2c02837 |
0.453 |
|
| 2022 |
Vipparthi K, Hari K, Chakraborty P, Ghosh S, Patel AK, Ghosh A, Biswas NK, Sharan R, Arun P, Jolly MK, Singh S. Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer. Iscience. 25: 104317. PMID 35602941 DOI: 10.1016/j.isci.2022.104317 |
0.406 |
|
| 2022 |
Vilchez Mercedes SA, Bocci F, Ahmed M, Eder I, Zhu N, Levine H, Onuchic JN, Jolly MK, Wong PK. Nrf2 Modulates the Hybrid Epithelial/Mesenchymal Phenotype and Notch Signaling During Collective Cancer Migration. Frontiers in Molecular Biosciences. 9: 807324. PMID 35480877 DOI: 10.3389/fmolb.2022.807324 |
0.644 |
|
| 2022 |
Jain P, Bhatia S, Thompson EW, Jolly MK. Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells. Biomolecules. 12. PMID 35327538 DOI: 10.3390/biom12030348 |
0.368 |
|
| 2022 |
Masuda H, Harano K, Miura S, Wang Y, Hirota Y, Harada O, Jolly MK, Matsunaga Y, Lim B, Wood AL, Parinyanitikul N, Jin Lee H, Gong G, George JT, Levine H, et al. Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy. Jco Precision Oncology. 6: e2000368. PMID 35294223 DOI: 10.1200/PO.20.00368 |
0.462 |
|
| 2022 |
Tretyakova MS, Subbalakshmi AR, Menyailo ME, Jolly MK, Denisov EV. Tumor Hybrid Cells: Nature and Biological Significance. Frontiers in Cell and Developmental Biology. 10: 814714. PMID 35242760 DOI: 10.3389/fcell.2022.814714 |
0.38 |
|
| 2022 |
Muralidharan S, Sahoo S, Saha A, Chandran S, Majumdar SS, Mandal S, Levine H, Jolly MK. Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial-Hybrid-Mesenchymal Spectrum in Cancer. Biomolecules. 12. PMID 35204797 DOI: 10.3390/biom12020297 |
0.524 |
|
| 2022 |
Jia W, Jolly MK, Levine H. NRF2-dependent Epigenetic Regulation can Promote the Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Cell and Developmental Biology. 9: 828250. PMID 35118079 DOI: 10.3389/fcell.2021.828250 |
0.578 |
|
| 2022 |
Johnson KS, Hussein S, Chakraborty P, Muruganantham A, Mikhail S, Gonzalez G, Song S, Jolly MK, Toneff MJ, Benton ML, Lin YC, Taube JH. CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial-Mesenchymal Gene Expression. Cancers. 14. PMID 35008373 DOI: 10.3390/cancers14010209 |
0.388 |
|
| 2022 |
Sahoo S, Ashraf B, Duddu AS, Biddle A, Jolly MK. Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer. Clinical & Experimental Metastasis. PMID 34993766 DOI: 10.1007/s10585-021-10139-2 |
0.373 |
|
| 2022 |
Subbalakshmi AR, Ashraf B, Jolly MK. Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes. Physical Biology. 19. PMID 34986465 DOI: 10.1088/1478-3975/ac482c |
0.441 |
|
| 2022 |
Khumukcham SS, Penugurti V, Soni A, Uppala V, Hari K, Jolly MK, Dwivedi A, Salam Pk A, Padala C, Mukta S, Bhopal T, Manavathi B. A reciprocal feedback loop between HIF-1α and HPIP controls phenotypic plasticity in breast cancer cells. Cancer Letters. 526: 12-28. PMID 34767928 DOI: 10.1016/j.canlet.2021.11.002 |
0.365 |
|
| 2021 |
Mandal S, Tejaswi T, Janivara R, Srikrishnan S, Thakur P, Sahoo S, Chakraborty P, Sohal SS, Levine H, George JT, Jolly MK. Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts. Biomolecules. 12. PMID 35053177 DOI: 10.3390/biom12010029 |
0.553 |
|
| 2021 |
Nam A, Mohanty A, Bhattacharya S, Kotnala S, Achuthan S, Hari K, Srivastava S, Guo L, Nathan A, Chatterjee R, Jain M, Nasser MW, Batra SK, Rangarajan G, Massarelli E, ... ... Jolly MK, et al. Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy. Biomolecules. 12. PMID 35053156 DOI: 10.3390/biom12010008 |
0.515 |
|
| 2021 |
Sahoo S, Nayak SP, Hari K, Purkait P, Mandal S, Kishore A, Levine H, Jolly MK. Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Immunology. 12: 797261. PMID 34975907 DOI: 10.3389/fimmu.2021.797261 |
0.552 |
|
| 2021 |
Subbalakshmi AR, Sahoo S, McMullen I, Saxena AN, Venugopal SK, Somarelli JA, Jolly MK. KLF4 Induces Mesenchymal-Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors. Cancers. 13. PMID 34680284 DOI: 10.3390/cancers13205135 |
0.403 |
|
| 2021 |
Roy N, Kshattry M, Mandal S, Jolly MK, Bhattacharyya DK, Barah P. An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis. Journal of Clinical Medicine. 10. PMID 34441816 DOI: 10.3390/jcm10163520 |
0.308 |
|
| 2021 |
Norgard RJ, Pitarresi JR, Maddipati R, Aiello-Couzo NM, Balli D, Li J, Yamazoe T, Wengyn MD, Millstein ID, Folkert IW, Rosario-Berrios DN, Kim IK, Bassett JB, Payne R, Berry CT, ... ... Jolly MK, et al. Calcium signaling induces a partial EMT. Embo Reports. e51872. PMID 34324787 DOI: 10.15252/embr.202051872 |
0.409 |
|
| 2021 |
Sahoo S, Mishra A, Kaur H, Hari K, Muralidharan S, Mandal S, Jolly MK. A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells. Nar Cancer. 3: zcab027. PMID 34316714 DOI: 10.1093/narcan/zcab027 |
0.345 |
|
| 2021 |
Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers. 13. PMID 34298815 DOI: 10.3390/cancers13143602 |
0.373 |
|
| 2021 |
Vilchez Mercedes SA, Bocci F, Levine H, Onuchic JN, Jolly MK, Wong PK. Decoding leader cells in collective cancer invasion. Nature Reviews. Cancer. PMID 34239104 DOI: 10.1038/s41568-021-00376-8 |
0.577 |
|
| 2021 |
Wang P, Zhou R, Thomas P, Zhao L, Zhou R, Mandal S, Jolly MK, Richard DJ, Rehm BHA, Ostrikov KK, Dai X, Williams ED, Thompson EW. Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems. Cancers. 13. PMID 34207708 DOI: 10.3390/cancers13122889 |
0.349 |
|
| 2021 |
Kvokačková B, Remšík J, Jolly MK, Souček K. Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial-Mesenchymal Plasticity. Cancers. 13. PMID 34063254 DOI: 10.3390/cancers13092188 |
0.447 |
|
| 2021 |
Deshmukh AP, Vasaikar SV, Tomczak K, Tripathi S, den Hollander P, Arslan E, Chakraborty P, Soundararajan R, Jolly MK, Rai K, Levine H, Mani SA. Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33941680 DOI: 10.1073/pnas.2102050118 |
0.55 |
|
| 2021 |
Jolly MK, Murphy RJ, Bhatia S, Whitfield HJ, Redfern A, Davis MJ, Thompson EW. Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications. Cells, Tissues, Organs. 1-24. PMID 33902034 DOI: 10.1159/000515289 |
0.367 |
|
| 2021 |
Jia D, Park JH, Kaur H, Jung KH, Yang S, Tripathi S, Galbraith M, Deng Y, Jolly MK, Kaipparettu BA, Onuchic JN, Levine H. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. British Journal of Cancer. PMID 33859341 DOI: 10.1038/s41416-021-01385-y |
0.531 |
|
| 2021 |
Deng Y, Chakraborty P, Jolly MK, Levine H. A Theoretical Approach to Coupling the Epithelial-Mesenchymal Transition (EMT) to Extracellular Matrix (ECM) Stiffness via LOXL2. Cancers. 13. PMID 33807227 DOI: 10.3390/cancers13071609 |
0.541 |
|
| 2021 |
Chauhan L, Ram U, Hari K, Jolly MK. Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer. Elife. 10. PMID 33729159 DOI: 10.7554/eLife.64522 |
0.317 |
|
| 2021 |
Singh D, Bocci F, Kulkarni P, Jolly MK. Coupled Feedback Loops Involving PAGE4, EMT and Notch Signaling Can Give Rise to Non-genetic Heterogeneity in Prostate Cancer Cells. Entropy (Basel, Switzerland). 23. PMID 33652914 DOI: 10.3390/e23030288 |
0.314 |
|
| 2021 |
Subbalakshmi AR, Sahoo S, Biswas K, Jolly MK. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT). Cells, Tissues, Organs. 1-14. PMID 33567424 DOI: 10.1159/000512520 |
0.449 |
|
| 2021 |
Chakraborty P, George JT, Woodward WA, Levine H, Jolly MK. Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum. Translational Oncology. 14: 101026. PMID 33535154 DOI: 10.1016/j.tranon.2021.101026 |
0.457 |
|
| 2021 |
Chedere A, Hari K, Kumar S, Rangarajan A, Jolly MK. Multi-Stability and Consequent Phenotypic Plasticity in AMPK-Akt Double Negative Feedback Loop in Cancer Cells. Journal of Clinical Medicine. 10. PMID 33530625 DOI: 10.3390/jcm10030472 |
0.371 |
|
| 2021 |
Tripathi S, Xing J, Levine H, Jolly MK. Mathematical Modeling of Plasticity and Heterogeneity in EMT. Methods in Molecular Biology (Clifton, N.J.). 2179: 385-413. PMID 32939734 DOI: 10.1007/978-1-0716-0779-4_28 |
0.576 |
|
| 2020 |
Tripathi SC, Jolly MK, Mani SA, Levine H. Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity. Frontiers in Molecular Biosciences. 7: 630276. PMID 33553244 DOI: 10.3389/fmolb.2020.630276 |
0.469 |
|
| 2020 |
Subbalakshmi AR, Kundnani D, Biswas K, Ghosh A, Hanash SM, Tripathi SC, Jolly MK. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Oncology. 10: 553342. PMID 33014880 DOI: 10.3389/fonc.2020.553342 |
0.637 |
|
| 2020 |
Saxena K, Srikrishnan S, Celia-Terrassa T, Jolly MK. OVOL1/2: Drivers of Epithelial Differentiation in Development, Disease, and Reprogramming. Cells, Tissues, Organs. 1-10. PMID 32932250 DOI: 10.1159/000511383 |
0.408 |
|
| 2020 |
Thankamony AP, Murali R, Karthikeyan N, Varghese BA, Teo WS, McFarland A, Roden DL, Holliday H, Konrad CV, Cazet A, Dodson E, Yang J, Baker LA, George JT, Levine H, ... Jolly MK, et al. Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy. Biomolecules. 10. PMID 32911668 DOI: 10.3390/biom10091295 |
0.524 |
|
| 2020 |
Bocci F, Onuchic JN, Jolly MK. Understanding the Principles of Pattern Formation Driven by Notch Signaling by Integrating Experiments and Theoretical Models. Frontiers in Physiology. 11: 929. PMID 32848867 DOI: 10.3389/Fphys.2020.00929 |
0.364 |
|
| 2020 |
Saxena K, Jolly MK, Balamurugan K. Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis. Translational Oncology. 13: 100845. PMID 32781367 DOI: 10.1016/j.tranon.2020.100845 |
0.488 |
|
| 2020 |
Gearhart-Serna LM, Davis JB, Jolly MK, Jayasundara N, Sauer SJ, Di Giulio RT, Devi GR. A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells. Carcinogenesis. PMID 32747956 DOI: 10.1093/Carcin/Bgaa047 |
0.335 |
|
| 2020 |
Jia W, Tripathi S, Chakraborty P, Chedere A, Rangarajan A, Levine H, Jolly MK. Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT. Oncotarget. 11: 2611-2624. PMID 32676163 DOI: 10.18632/oncotarget.27651 |
0.575 |
|
| 2020 |
Thankamony AP, Saxena K, Murali R, Jolly MK, Nair R. Cancer Stem Cell Plasticity - A Deadly Deal. Frontiers in Molecular Biosciences. 7: 79. PMID 32426371 DOI: 10.3389/fmolb.2020.00079 |
0.423 |
|
| 2020 |
Khot M, Sreekumar D, Jahagirdar S, Kulkarni A, Hari K, Faseela EE, Sabarinathan R, Jolly MK, Sengupta K. Twist1 induces chromosomal instability (CIN) in colorectal cancer cells. Human Molecular Genetics. PMID 32337580 DOI: 10.1093/hmg/ddaa076 |
0.32 |
|
| 2020 |
Iyer A, Gupta K, Sharma S, Hari K, Lee YF, Ramalingam N, Yap YS, West J, Bhagat AA, Subramani BV, Sabuwala B, Tan TZ, Thiery JP, Jolly MK, Ramalingam N, et al. Integrative Analysis and Machine Learning based Characterization of Single Circulating Tumor Cells. Journal of Clinical Medicine. 9. PMID 32331451 DOI: 10.3390/jcm9041206 |
0.374 |
|
| 2020 |
Drápela S, Bouchal J, Jolly MK, Culig Z, Souček K. ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance. Frontiers in Molecular Biosciences. 7: 36. PMID 32266287 DOI: 10.3389/fmolb.2020.00036 |
0.362 |
|
| 2020 |
Chakraborty P, George JT, Tripathi S, Levine H, Jolly MK. Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum. Frontiers in Bioengineering and Biotechnology. 8: 220. PMID 32266244 DOI: 10.3389/fbioe.2020.00220 |
0.621 |
|
| 2020 |
Dhadve AC, Hari K, Rekhi B, Jolly MK, De A, Ray P. Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165754. PMID 32142859 DOI: 10.1016/j.bbadis.2020.165754 |
0.307 |
|
| 2020 |
Tripathi S, Chakraborty P, Levine H, Jolly MK. A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells. Plos Computational Biology. 16: e1007619. PMID 32040502 DOI: 10.1371/journal.pcbi.1007619 |
0.591 |
|
| 2020 |
Tripathi S, Levine H, Jolly MK. The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition. Annual Review of Biophysics. PMID 31913665 DOI: 10.1146/annurev-biophys-121219-081557 |
0.59 |
|
| 2020 |
Celià-Terrassa T, Jolly MK. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis. Cold Spring Harbor Perspectives in Medicine. 10. PMID 31570380 DOI: 10.1101/cshperspect.a036905 |
0.436 |
|
| 2019 |
Sarkar S, Sinha SK, Levine H, Jolly MK, Dutta PS. Anticipating critical transitions in epithelial-hybrid-mesenchymal cell-fate determination. Proceedings of the National Academy of Sciences of the United States of America. PMID 31843939 DOI: 10.1073/pnas.1913773116 |
0.607 |
|
| 2019 |
Lourenco AR, Ban Y, Crowley MJ, Lee SB, Ramchandani D, Du W, Elemento O, George JT, Jolly MK, Levine H, Sheng J, Wong STC, Altorki NK, Gao D. Differential contributions of pre- and post- EMT tumor cells in breast cancer metastasis. Cancer Research. PMID 31704888 DOI: 10.1158/0008-5472.Can-19-1427 |
0.602 |
|
| 2019 |
Kang TY, Bocci F, Jolly MK, Levine H, Onuchic JN, Levchenko A. Pericytes enable effective angiogenesis in the presence of proinflammatory signals. Proceedings of the National Academy of Sciences of the United States of America. PMID 31685607 DOI: 10.1073/Pnas.1913373116 |
0.427 |
|
| 2019 |
Thangavel H, Angelis C, Vasaikar S, Bhat R, Jolly MK, Nagi C, Creighton CJ, Chen F, Dobrolecki LE, George JT, Kumar T, Abdulkareem NM, Mao S, Nardone A, Rimawi M, et al. A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. Journal of Clinical Medicine. 8. PMID 31652963 DOI: 10.3390/Jcm8111772 |
0.508 |
|
| 2019 |
Kalvala A, Wallet P, Yang L, Wang C, Li H, Nam A, Nathan A, Mambetsariev I, Poroyko V, Gao H, Chu P, Sattler M, Bild A, Manuel ER, Lee PP, ... Jolly MK, et al. Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS. Journal of Clinical Medicine. 8. PMID 31635338 DOI: 10.3390/Jcm8101726 |
0.345 |
|
| 2019 |
Yang Y, Jolly MK, Levine H. Computational Modeling of Collective Cell Migration: Mechanical and Biochemical Aspects. Advances in Experimental Medicine and Biology. 1146: 1-11. PMID 31612450 DOI: 10.1007/978-3-030-17593-1_1 |
0.534 |
|
| 2019 |
Jolly MK, Celià-Terrassa T. Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression. Journal of Clinical Medicine. 8. PMID 31557977 DOI: 10.3390/jcm8101542 |
0.441 |
|
| 2019 |
Nath B, Bidkar AP, Kumar V, Dalal A, Jolly MK, Ghosh SS, Biswas G. Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary. Journal of Clinical Medicine. 8. PMID 31404980 DOI: 10.3390/Jcm8081194 |
0.399 |
|
| 2019 |
Jia W, Deshmukh A, Mani SA, Jolly MK, Levine H. A possible role for epigenetic feedback regulation in the dynamics of the Epithelial-Mesenchymal Transition (EMT). Physical Biology. PMID 31342918 DOI: 10.1088/1478-3975/Ab34Df |
0.539 |
|
| 2019 |
Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, Hanash SM, Levine H, Onuchic JN, Jolly MK. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 31329868 DOI: 10.1093/Intbio/Zyz021 |
0.715 |
|
| 2019 |
Varankar SS, More M, Abraham A, Pansare K, Kumar B, Narayanan NJ, Jolly MK, Mali AM, Bapat SA. Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines. Carcinogenesis. PMID 31241128 DOI: 10.1093/carcin/bgz119 |
0.437 |
|
| 2019 |
Jia D, Li X, Bocci F, Tripathi S, Deng Y, Jolly MK, Onuchic JN, Levine H. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. Journal of Clinical Medicine. 8. PMID 31121840 DOI: 10.3390/Jcm8050725 |
0.647 |
|
| 2019 |
Jolly MK, Ware KE, Xu S, Gilja S, Shetler S, Yang Y, Wang X, Austin RG, Runyambo D, Hish AJ, Bartholf DeWitt S, George JT, Kreulen RT, Boss MK, Lazarides AL, et al. E-cadherin represses anchorage-independent growth in sarcomas through both signaling and mechanical mechanisms. Molecular Cancer Research : McR. PMID 30862685 DOI: 10.1158/1541-7786.Mcr-18-0763 |
0.538 |
|
| 2019 |
Lin X, Kulkarni P, Bocci F, Schafer NP, Roy S, Tsai MY, He Y, Chen Y, Rajagopalan K, Mooney SM, Zeng Y, Weninger K, Grishaev A, Onuchic JN, Levine H, ... ... Jolly MK, et al. Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level. Biomolecules. 9. PMID 30813315 DOI: 10.3390/biom9020077 |
0.417 |
|
| 2019 |
Xu S, Ware KE, Ding Y, Kim SY, Sheth MU, Rao S, Chan W, Armstrong AJ, Eward WC, Jolly MK, Somarelli JA. An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance. Journal of Clinical Medicine. 8. PMID 30736412 DOI: 10.3390/Jcm8020205 |
0.311 |
|
| 2019 |
Shinde A, Hardy SD, Kim D, Akhand SS, Jolly MK, Wang WH, Anderson JC, Khodadadi RB, Brown WS, George JT, Liu S, Wan J, Levine H, Willey CD, Krusemark CJ, et al. Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer. Cancer Research. PMID 30733195 DOI: 10.1158/0008-5472.Can-18-2636 |
0.569 |
|
| 2019 |
Li X, Jolly MK, George JT, Pienta KJ, Levine H. Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment. Frontiers in Oncology. 9: 10. PMID 30729096 DOI: 10.3389/fonc.2019.00010 |
0.562 |
|
| 2019 |
Bocci F, Jolly MK, Levine H, Onuchic JN. Quantitative Characteristic of ncRNA Regulation in Gene Regulatory Networks. Methods in Molecular Biology (Clifton, N.J.). 1912: 341-366. PMID 30635901 DOI: 10.1007/978-1-4939-8982-9_14 |
0.411 |
|
| 2019 |
Bocci F, Gearhart-Serna L, Boareto M, Ribeiro M, Ben-Jacob E, Devi GR, Levine H, Onuchic JN, Jolly MK. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America. 116: 148-157. PMID 30587589 DOI: 10.1073/Pnas.1815345116 |
0.708 |
|
| 2018 |
Jolly MK, Preca BT, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T, Stemmler MP, Maurer J, Levine H. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. Apl Bioengineering. 2: 031908. PMID 31069317 DOI: 10.1063/1.5024874 |
0.728 |
|
| 2018 |
Jia D, George J, Tripathi S, Kundnani D, Lu M, Hanash S, Onuchic J, Jolly MK, Levine H. Testing the gene expression classification of the EMT spectrum. Physical Biology. PMID 30557866 DOI: 10.1088/1478-3975/Aaf8D4 |
0.669 |
|
| 2018 |
Biswas K, Jolly MK, Ghosh A. Stability and mean residence times for hybrid epithelial/mesenchymal phenotype. Physical Biology. PMID 30537698 DOI: 10.1088/1478-3975/aaf7b7 |
0.453 |
|
| 2018 |
Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacology & Therapeutics. PMID 30268772 DOI: 10.1016/J.Pharmthera.2018.09.007 |
0.727 |
|
| 2018 |
Bocci F, Jolly MK, George JT, Levine H, Onuchic JN. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling. Oncotarget. 9: 29906-29920. PMID 30042822 DOI: 10.18632/Oncotarget.25692 |
0.633 |
|
| 2018 |
Tripathi S, Jolly MK, Woodward WA, Levine H, Deem MW. Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer. Frontiers in Oncology. 8: 244. PMID 30023340 DOI: 10.3389/Fonc.2018.00244 |
0.534 |
|
| 2018 |
Jolly MK, Mani SA, Levine H. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis? Biochimica Et Biophysica Acta. PMID 29997040 DOI: 10.1016/J.Bbcan.2018.07.001 |
0.612 |
|
| 2018 |
Lin X, Roy S, Jolly MK, Bocci F, Schafer NP, Tsai MY, Chen Y, He Y, Grishaev A, Weninger K, Orban J, Kulkarni P, Rangarajan G, Levine H, Onuchic JN. PAGE4 and Conformational Switching: Insights from Molecular Dynamics Simulations and Implications for Prostate Cancer. Journal of Molecular Biology. PMID 29758263 DOI: 10.1016/J.Jmb.2018.05.011 |
0.437 |
|
| 2018 |
Jolly MK, Kulkarni P, Weninger K, Orban J, Levine H. Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity. Frontiers in Oncology. 8: 50. PMID 29560343 DOI: 10.3389/Fonc.2018.00050 |
0.47 |
|
| 2018 |
Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Research. PMID 29351901 DOI: 10.1158/0008-5472.Can-17-1667 |
0.538 |
|
| 2017 |
Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H. Distinguishing mechanisms underlying EMT tristability. Cancer Convergence. 1: 2. PMID 29623961 DOI: 10.1186/s41236-017-0005-8 |
0.736 |
|
| 2017 |
Bocci F, Jolly MK, Tripathi SC, Aguilar M, Hanash SM, Levine H, Onuchic JN. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. Journal of the Royal Society, Interface. 14. PMID 29187638 DOI: 10.1098/Rsif.2017.0512 |
0.728 |
|
| 2017 |
George JT, Jolly MK, Xu J, Somarelli J, Levine H. Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Research. PMID 28947416 DOI: 10.1158/0008-5472.Can-16-3521 |
0.625 |
|
| 2017 |
Jolly MK, Boareto M, Debeb BG, Aceto N, Farach-Carson MC, Woodward WA, Levine H. Inflammatory breast cancer: a model for investigating cluster-based dissemination. Npj Breast Cancer. 3: 21. PMID 28649661 DOI: 10.1038/s41523-017-0023-9 |
0.535 |
|
| 2017 |
Jolly MK, Ward C, Eapen MS, Myers S, Hallgren O, Levine H, Sohal SS. Epithelial mesenchymal transition (EMT), a spectrum of states: role in lung development, homeostasis and disease. Developmental Dynamics : An Official Publication of the American Association of Anatomists. PMID 28646553 DOI: 10.1002/Dvdy.24541 |
0.45 |
|
| 2017 |
Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM. MCAM mediates chemoresistance in small cell lung cancer via the PI3K/AKT/SOX2 signaling pathway. Cancer Research. PMID 28646020 DOI: 10.1158/0008-5472.CAN-16-2874 |
0.651 |
|
| 2017 |
Jia D, Jolly MK, Kulkarni P, Levine H. Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory. Cancers. 9. PMID 28640191 DOI: 10.3390/cancers9070070 |
0.599 |
|
| 2017 |
Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H. Epithelial-mesenchymal plasticity: How have quantitative mathematical models helped improve our understanding? Molecular Oncology. PMID 28548388 DOI: 10.1002/1878-0261.12084 |
0.686 |
|
| 2017 |
Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Molecular Oncology. PMID 28548345 DOI: 10.1002/1878-0261.12083 |
0.569 |
|
| 2017 |
Ware KE, Gilja S, Xu S, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Jordan S, Eward W, Levine H, Armstrong AJ, Somarelli JA. Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. Journal of Visualized Experiments : Jove. PMID 28448023 DOI: 10.3791/55520 |
0.579 |
|
| 2017 |
Jia D, Jolly MK, Harrison W, Boareto M, Ben-Jacob E, Levine H. Operating principles of tristable circuits regulating cellular differentiation. Physical Biology. PMID 28443829 DOI: 10.1088/1478-3975/Aa6F90 |
0.574 |
|
| 2017 |
Kulkarni P, Jolly MK, Jia D, Mooney SM, Bhargava A, Kagohara LT, Chen Y, Hao P, He Y, Veltri RW, Grishaev A, Weninger K, Levine H, Orban J. Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. PMID 28289210 DOI: 10.1073/Pnas.1700082114 |
0.442 |
|
| 2017 |
Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H, McConkey BJ. The GRHL2/ZEB Feedback Loop - A Key Axis in the Regulation of EMT in Breast Cancer. Journal of Cellular Biochemistry. PMID 28266048 DOI: 10.1002/Jcb.25974 |
0.584 |
|
| 2016 |
Mooney SM, Jolly MK, Levine H, Kulkarni P. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian Journal of Andrology. PMID 27427552 DOI: 10.4103/1008-682X.183570 |
0.544 |
|
| 2016 |
Somarelli JA, Shelter S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Gilja S, Eward WC, Ware KE, Levine H, Armstrong AJ, Garcia-Blanco MA. Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of miR-200s and GRHL2. Molecular and Cellular Biology. PMID 27402864 DOI: 10.1128/Mcb.00373-16 |
0.543 |
|
| 2016 |
Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. Journal of the Royal Society, Interface / the Royal Society. 13. PMID 27170649 DOI: 10.1098/Rsif.2015.1106 |
0.688 |
|
| 2016 |
Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor Budding: The Name is EMT. Partial EMT. Journal of Clinical Medicine. 5. PMID 27136592 DOI: 10.3390/Jcm5050051 |
0.534 |
|
| 2016 |
Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget. PMID 27008704 DOI: 10.18632/Oncotarget.8166 |
0.766 |
|
| 2016 |
Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, et al. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929325 DOI: 10.1073/Pnas.1521812113 |
0.689 |
|
| 2015 |
Huang B, Jolly MK, Lu M, Tsarfaty I, Ben-Jacob E, Onuchic JN. Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis. Scientific Reports. 5: 17379. PMID 26627083 DOI: 10.1038/Srep17379 |
0.609 |
|
| 2015 |
Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget. PMID 26317796 DOI: 10.18632/Oncotarget.4629 |
0.658 |
|
| 2015 |
Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Frontiers in Oncology. 5: 155. PMID 26258068 DOI: 10.3389/Fonc.2015.00155 |
0.714 |
|
| 2015 |
Boareto M, Jolly MK, Ben-Jacob E, Onuchic JN. Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision. Proceedings of the National Academy of Sciences of the United States of America. 112: E3836-44. PMID 26153421 DOI: 10.1073/Pnas.1511814112 |
0.546 |
|
| 2015 |
Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, Levine H, Ben-Jacob E. OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget. PMID 25944618 DOI: 10.18632/Oncotarget.3623 |
0.721 |
|
| 2015 |
Boareto M, Jolly MK, Lu M, Onuchic JN, Clementi C, Ben-Jacob E. Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proceedings of the National Academy of Sciences of the United States of America. 112: E402-9. PMID 25605936 DOI: 10.1073/Pnas.1416287112 |
0.525 |
|
| 2014 |
Jolly MK, Huang B, Lu M, Mani SA, Levine H, Ben-Jacob E. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. Journal of the Royal Society, Interface / the Royal Society. 11: 20140962. PMID 25339690 DOI: 10.1098/Rsif.2014.0962 |
0.663 |
|
| 2014 |
Huang B, Lu M, Jolly MK, Tsarfaty I, Onuchic J, Ben-Jacob E. The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Scientific Reports. 4: 6449. PMID 25245029 DOI: 10.1038/Srep06449 |
0.563 |
|
| 2014 |
Lu M, Jolly MK, Onuchic J, Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Research. 74: 4574-87. PMID 25183783 DOI: 10.1158/0008-5472.Can-13-3367 |
0.561 |
|
| 2013 |
Lu M, Jolly MK, Levine H, Onuchic JN, Ben-Jacob E. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proceedings of the National Academy of Sciences of the United States of America. 110: 18144-9. PMID 24154725 DOI: 10.1073/Pnas.1318192110 |
0.655 |
|
| 2013 |
Lu M, Jolly MK, Gomoto R, Huang B, Onuchic J, Ben-Jacob E. Tristability in cancer-associated microRNA-TF chimera toggle switch. The Journal of Physical Chemistry. B. 117: 13164-74. PMID 23679052 DOI: 10.1021/Jp403156M |
0.511 |
|
| Show low-probability matches. |